BROS vs EBS · P/E 105, rev $1.28B vs rev $1.04B
Dutch Bros Inc (BROS) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BROS revenue for 2024-12-31 was $1.28B. Net income was $66.5M. Revenue was up 32.6% from 2023-12-31 to 2024-12-31. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
BROS currently screens at market cap $11.74B and trailing P/E 105.0. EBS currently screens at market cap $416.4M.
Not investment advice. Open the BROS and EBS stock pages for the full models.
Not investment advice.